Browsing Tag
RenovoRx
3 posts
How the TIGeR-PaC sub-study could influence future thinking around chemotherapy tolerability and precision delivery
RenovoRx’s TIGeR-PaC sub-study highlights how targeted chemotherapy delivery could reshape pancreatic cancer treatment strategy. Read more.
SIR 2026 annual scientific meeting: what interventional radiologists need to know about Toronto
SIR 2026 runs April 11-15 at the Metro Toronto Convention Centre. Over 4,000 IR professionals, 400+ presentations, robotics, ablation and AI sessions covered.
How the Japan patent allowance could strengthen RenovoRx’s oncology platform valuation story
Could RenovoRx’s Japan patent strengthen the RNXT valuation story? Read what this means for growth, competition, and investor sentiment.